Alternative Data for Dexcom
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 354 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 3,637,000 | Sign up | Sign up | Sign up |
| Employee Rating | 72 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 11,653 | Sign up | Sign up | Sign up |
| Facebook Followers | 229,940 | Sign up | Sign up | Sign up |
| Instagram Followers | 186,334 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 23 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 10,076 | Sign up | Sign up | Sign up |
| X Followers | 8,853 | Sign up | Sign up | Sign up |
| X Mentions | 7 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 49,800 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 65 | Sign up | Sign up | Sign up |
| Linkedin Employees | 8,157 | Sign up | Sign up | Sign up |
About Dexcom
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
| Price | $73.67 |
| Target Price | Sign up |
| Volume | 5,640,000 |
| Market Cap | $28.8B |
| Year Range | $54.84 - $89.53 |
| Dividend Yield | 0% |
| PE Ratio | 40.74 |
| Analyst Rating | 87% buy |
| Earnings Date | February 12 '26 |
| Industry | Medical Devices |
In the news
Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core SegmentsJanuary 27 - Yahoo Entertainment |
|
 |
Much to admire as Leinster spoil opening day at Dexcom StadiumJanuary 24 - Independent.ie |
 |
Assessing DexCom (DXCM) Valuation After Recent Share Price Momentum And Conflicting Fair Value SignalsJanuary 19 - Yahoo |
 |
Connacht v Montauban: Western province aim to make Challenge Cup last-16 at DexcomJanuary 17 - Independent.ie |
 |
DexCom (DXCM) Releases Preliminary, Unaudited Results for Q4 2025January 14 - Yahoo Entertainment |
|
How Investors May Respond To DexCom (DXCM) Strong 2025 Revenue Beat And 2026 Growth OutlookJanuary 13 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 1.21B | 478M | 731M | 284M | 421M | 0.610 |
| Q2 '25 | 1.16B | 468M | 689M | 180M | 309M | 0.480 |
| Q1 '25 | 1.04B | 447M | 589M | 105M | 219M | 0.320 |
| Q4 '24 | 1.11B | 458M | 656M | 152M | 274M | 0.380 |
| Q3 '24 | 994M | 400M | 594M | 135M | 237M | 0.450 |
Insider Transactions View All
| Collins Richard Alexander filed to sell 35,088 shares at $59.1. November 17 '25 |
| Heller Bridgette P filed to sell 27,031 shares at $58.1. November 12 '25 |
| Leach Jacob Steven filed to buy 331,697 shares at $55.4. November 10 '25 |
| Leach Jacob Steven filed to buy 329,197 shares at $55. November 10 '25 |
| Collins Richard Alexander filed to sell 37,994 shares at $55.2. November 10 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Michael McCaul |
Oct 13, 25 | Buy | $1K - $15K |
| Michael McCaul |
Jul 9, 25 | Sell | $15K - $50K |
| Michael McCaul |
Jul 9, 25 | Buy | $15K - $50K |
Read more about Dexcom (DXCM) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Dexcom
The Market Cap of Dexcom is $28.8B.
As of today, Dexcom's PE (Price to Earnings) ratio is 40.74.
Dexcom will report its next earnings on February 12 '26.
Currently, the price of one share of Dexcom stock is $73.67.
The DXCM stock price chart above provides a comprehensive visual representation of Dexcom's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Dexcom shares. Our platform offers an up-to-date DXCM stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Dexcom (DXCM) does not offer dividends to its shareholders. Investors interested in Dexcom should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Dexcom are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
